MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

Home » Mela adds five to board of directors to replace four outgoing members | Personnel Moves

Mela adds five to board of directors to replace four outgoing members | Personnel Moves

By

Mela Sciences logo

Mela Sciences (NSDQ:MELA) added five new members to its board of directors this month, looking to tap their expertise in advance of a planned launch in the U.S. and Germany in the first quarter of 2012.

The Irvington, N.Y.-based company named the new directors on the heels of two regulatory wins granting its flagship skin cancer detection device MelaFind market access in the U.S. and Europe.

Mela won FDA clearance early last month after more than two years in regulatory limbo, and landed CE Mark approval in the European Union in September.

"The FDA approval of MelaFind marks the most important achievement in the company’s history and represents a significant advance for the millions of Americans who are at risk of developing this terrible disease," president & CEO Dr. Joseph Gulfo said in November.

Click here to listen to the MassDevice podcast interview with Mela Sciences CEO Dr. Joseph Gulfo

Mela’s new board members come in to replace outgoing directors Sidney Braginsky and George Chryssis, both members since 2001, as well as Breaux Castleman, member since 2003, and Gerald Wagner, director since 2005.

Dr. Gulfo added, "Having achieved FDA and CE Mark approvals in 2011, it is with bittersweet emotion that we effect these changes to our Board, saying goodbye to directors who have served multiple tours in our fight to win the product approvals," president & CEO Joseph Gulfo said in prepared remarks. "We sincerely thank Messrs. Braginsky, Castleman, Chryssis and Dr. Wagner for their excellent contributions, without which we could not have succeeded, and we wish them well."

Mela’s new directors are:

  • Robert Coradini, Johnson & Johnson (NYSE:JNJ) veteran.

  • Mark Fabiani, former special counsel to President Clinton.
  • John Goddard, former CFO for AstraZeneca U.S.
  • James Noble, CEO of Immunocore
  • David Stone, founder and managing director of Liberty Tree Advisors, LLC

    "With FDA and CE Mark approval of our breakthrough product, MelaFind, we are now a commercial-stage company, and we look to the expertise of our new directors in the fields of international sales and marketing, investor and public relations, accounting, business development, and strategic planning as we prepare for our first quarter 2012 product launches in the US and Germany," said Gulfo added.

    MassDevice.com Personnel Moves

    Here’s the latest personnel changes from medical device, diagnostics and life science companies around the nation. For more recent hirings and firings, check out MassDevice’s compilation of the latest personnel moves.

    Intrinsic Therapeutics names new president & CEO
    Woburn, Mass.-based spinal therapies maker Intrinsic Therapeutics named Cary Hagan president & CEO. Read more

    DJO Global announces COO departure
    DJO Global Inc., a global provider of medical device solutions for musculoskeletal health, vascular health and pain management, announced the resignation of Luke Faulstick, executive VP and COO, who will depart in early February, 2012.  Read more

    Competitive Technologies gets new board chairman
    Competitive Technologies Inc. (PINK:CTTC) announced that Rustin R. Howard, who has served as a director of CTTC since October of 2007, has been elected chairman of its board of directors, effective immediately.   Read more

    SuccessEHS names new chief medical officer
    SuccessEHS named Dr. Claude Ouimet, former deputy health officer at Jefferson County Dept. of Health, its new chief medical officer.  Read more

In case you missed it

RSS From Medical Design & Outsourcing

  • Smith+Nephew expands reach of its Cori handheld robotic system
    A year after Smith+Nephew (NYSE:SNN) launched its Cori handheld robotic system in the U.S.,  the ortho surgery system has launched globally. The British medtech giant has expanded Cori’s reach to Europe, Australia and New Zealand, India, and Canada (just announced today). The company yesterday said the system was now available for use in the U.K.’s National Health… […]
  • Elizabeth Holmes reportedly expresses remorse in criminal fraud trial
    Elizabeth Holmes reportedly revealed some regret over her handling of business as the ex-Theranos CEO took the stand again in a criminal fraud trial. Taking the stand yesterday for the third day of testimony in federal court in San Jose, California, Holmes was said to have shown remorse while still shifting some of the blame… […]
  • Supply chain, manufacturing issues slow Medtronic’s Hugo launch, ramp-up expected next fiscal year
    Medtronic (NYSE:MDT) Chair & CEO Geoff Martha confirmed that the launch of the Hugo surgical robot platform is off-schedule. Hugo received CE mark approval last month. The company is gearing up to conduct its FDA investigational device exemption (IDE) clinical trials in the U.S., with more on its stateside efforts still to come, Medtronic’s surgical robotics… […]
  • Minnetronix Medical honored in Minnesota for its MindsEye Expandable Port
    Minnetronix Medical (St. Paul, Minn.) received an award from the Minnesota Technology Association that highlights its MindsEye Expandable Port for minimally invasive deep brain access. The company won the association’s TEKNE award for best medical technology and devices. “Given Minnesota is a global epicenter for the medical device industry, this award is quite meaningful to Minnetronix… […]
  • BD expands biosciences business with reagent innovation center in San Diego
    A life sciences real estate developer announced today that BD (NYSE:BDX) selected its property as a new facility for its biosciences business. Through a joint venture with Tishman Speyer and Bellco Capital, Breakthrough Properties confirmed that BD chose its Torrey View by Breakthrough property for an expanded San Diego reagent innovation center within its biosciences… […]
  • The best places to work for medtech sales reps in 2022
    Teleflex (NYSE:TFX), ConMed (NSDQ:CNMD) and Medtronic (NYSE:MDT) topped the list of best places to work in medtech sales in 2022, according to a MedReps.com survey of medical sales representatives. The 11th annual MedReps survey polled over 2,300 MedReps professionals to determine which medtech sales companies are most sought-after in the industry. Overall, pay and leadership were the most… […]
  • How medtech fared in the first waves of the pandemic
    Medtech industry revenue, research spending and employment declined in the first year of the COVID-19 pandemic, according to a Medical Design & Outsourcing analysis of financial data. Total sales, R&D spending and employment for the world’s largest medical device companies declined in 2020 and early 2021, according to a Medical Design & Outsourcing analysis tallying… […]
  • FreeStyle Libre 3, other Abbott products recognized at CES Innovation Awards
    Abbott (NYSE:ABT) was honored for a handful of its offerings at the Consumer Electronics Show (CES) 2022 Innovation Awards. The company’s FreeStyle Libre 3 continuous glucose monitoring (CGM) system ranked among the top 15 products in the CES Best of Innovation category. The next-generation CGM system features the world’s smallest, thinnest glucose sensor that can… […]
  • Evonik launches new Resomer PrintPowder polymers for 3D printing of personalized, implantable medical devices
    Evonik has launched the second generation of Resomer PrintPowder polymers for 3D printing of personalized, implantable medical devices. Essen, Germany-based Evokik said the powders have a broader range of customizable mechanical properties and degradation rates, allowing their use for more complex and tailored medical devices including orthopedic, dental, or soft tissue applications. “These new powders… […]
  • Tungsten cable for surgical robotics: Challenges solved introduce new unsolved challenges
    Tungsten cable is the perfect strength, flexibility, and diameter for surgical robots. Connor Chiuchiolo and Scott Dailey, Carl Stahl Sava Industries When manufacturing tungsten mechanical cable for surgical robotics, the tungsten itself presents enormous mechanical upside, including extraordinary tensile strength captured within astonishingly small diameters. What’s more, tungsten stranded into ultrafine mechanical cable possesses a remarkable… […]
  • FDA says Philips knew about toxic foam for years before massive recall
    The FDA said it observed potential violations of federal medical device safety rules when inspecting a Philips Respironics manufacturing facility connected to the Class I recall of more than 15 million respiratory devices. The FDA recently requested additional safety testing on replacement materials and issued a Form 483. The form details how Philips and its foam… […]

Leave a Reply